Wuxi Apptec
Wuxi Apptec, a leading global contract research, development, and manufacturing organisation (CRDMO), is headquartered in Wuxi, China. Founded in 2000, the company has expanded its operational footprint across North America, Europe, and Asia, establishing itself as a key player in the biopharmaceutical industry. Wuxi Apptec offers a comprehensive suite of services, including drug discovery, development, and manufacturing, which are distinguished by their innovative technologies and commitment to quality. The company has achieved significant milestones, such as the establishment of multiple state-of-the-art facilities and a robust portfolio of partnerships with major pharmaceutical firms. Recognised for its market leadership, Wuxi Apptec continues to drive advancements in the life sciences sector, providing essential support to clients in bringing new therapies to market efficiently and effectively.
DitchCarbon Score
How does Wuxi Apptec's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Wuxi Apptec's score of 55 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Wuxi Apptec's reported carbon emissions
In 2024, Wuxi AppTec reported total carbon emissions of approximately 2,287,403,590 kg CO2e. This figure includes Scope 1 emissions of about 66,471,640 kg CO2e, Scope 2 emissions of around 531,112,110 kg CO2e, and significant Scope 3 emissions totalling approximately 1,689,819,840 kg CO2e. The combined Scope 1 and 2 emissions amounted to about 597,583,750 kg CO2e. Wuxi AppTec has set ambitious greenhouse gas (GHG) reduction targets, aiming for a 25% reduction in GHG emissions intensity by 2030, starting from 2023. Additionally, the company has committed to reducing absolute Scope 1 and 2 emissions by 42% and Scope 3 emissions by 25% from a 2024 baseline, both by 2030. These targets align with the Science Based Targets initiative (SBTi) and are designed to support global efforts to limit temperature rise to 1.5°C. The company has consistently disclosed its emissions across all relevant scopes, demonstrating transparency in its climate commitments. Wuxi AppTec's proactive approach to reducing its carbon footprint reflects its commitment to sustainability within the pharmaceuticals and biotechnology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 6,643,770 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 144,938,320 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Wuxi Apptec is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
